Fluconazole, itraconazole, and ketoconazole have been reported to be teratogenic in rodents. Uses: AND administration: For vaginal candidiasis 150 mg as a single dose for one day of therapy.. Therapy for infections that needs multiple Doses should be continued until the clinical parameters and laboratory tests do not point out that the active mycotic infection is resolved. Dermatomycoses the usual doseis of 50 100 mg per day as a single administration during 14 28 days of therapy. Tinea pedis may require a treatment up to 42 days.
Fluconazole is distributed into breast milk, achieving concentrations similar to those found in matemal plasma, and its use in women who are breast feeding is not recommended .used with caution in patients with impaired hepatic or renal function. Abnormalities in haematological, hepatic, and renal-function tests have been observed
Adverse ef10cts: diarrhoea, flatulence, nausea and vomiting, and taste disturbance, and raised liver enzyme values.
Serious hepatotoxicity has been reported in patients with severe underlying disease such as AIDS or malignancy Oropharyngeal candidiasis including patients having compromised immune function, the usual doseis of 50 mg once a day for 7- 14 days, ttt can be prolonged during a longer time, especially in patients affected by serious immunode ression.
Capsule
مرة واحدة يوميا
51 EGP
Fluconazole, itraconazole, and ketoconazole have been reported to be teratogenic in rodents. Uses: AND administration: For vaginal candidiasis 150 mg as a single dose for one day of therapy.. Therapy for infections that needs multiple Doses should be continued until the clinical parameters and laboratory tests do not point out that the active mycotic infection is resolved. Dermatomycoses the usual doseis of 50 100 mg per day as a single administration during 14 28 days of therapy. Tinea pedis may require a treatment up to 42 days.
Fluconazole is distributed into breast milk, achieving concentrations similar to those found in matemal plasma, and its use in women who are breast feeding is not recommended .used with caution in patients with impaired hepatic or renal function. Abnormalities in haematological, hepatic, and renal-function tests have been observed
Adverse ef10cts: diarrhoea, flatulence, nausea and vomiting, and taste disturbance, and raised liver enzyme values.
Serious hepatotoxicity has been reported in patients with severe underlying disease such as AIDS or malignancy Oropharyngeal candidiasis including patients having compromised immune function, the usual doseis of 50 mg once a day for 7- 14 days, ttt can be prolonged during a longer time, especially in patients affected by serious immunode ression.
Note: All the provided information about this drug does not substitute for consulting a doctor.